The aspirin disease.
Schiavino
D
D
Department of Allergology, Università Cattolica S Cuore, Rome, Italy.
Nucera
E
E
Milani
A
A
Del Ninno
M
M
Buonomo
A
A
Sun
J
J
Patriarca
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced* / Q000628:therapy; D001798:Blood Proteins / Q000032:analysis; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D047091:Eosinophil Granule Proteins; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009298:Nasal Polyps / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D012260:Ribonucleases
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001798:Blood Proteins; D016861:Cyclooxygenase Inhibitors; D047091:Eosinophil Granule Proteins; D012260:Ribonucleases; D001241:Aspirin